FOXC2 and gastric cancer: In the present study, we provide the first evidence that FOXC2 promotes MDR in GC, observing that FOXC2 expression was elevated in MDR GC cells and GC tissue samples, and its overexpression was correlated with a poor prognosis in GC patients.